ALISON LEHNER is a partner and a member of the firm’s Global Life Sciences team. Alison represents life sciences companies at every life cycle stage. As a member of the Global Life Sciences team, Alison leverages a broad knowledge base to advise clients in a variety of transactional matters, including corporate and commercial matters, equity and debt financings, licensing, collaborations, co-promotions, and strategic transactions, including royalty and revenue financing and M&A.
While Alison represents clients of all sizes, a significant portion of practice involves working with entrepreneurs and inventors to develop companies that allow them to finance continued research and development outside of the academic environment. Alison also regularly works with investors in the life sciences industry as well as academic medical centers, allowing her to bring experience to all sides of emerging company transactions.
Alison has also advised clients on a broad range of issues related to cutting edge technology, such as digital heath and cell and gene therapies.